	Ebit		Date
Acadia Pharmaceuticals	USD 17.39M	18.36M	2025-12
Agios Pharmaceuticals	USD -121.58M	4.71M	2025-12
Alnylam Pharmaceuticals	USD 29.4M	59.36M	2025-12
BioCryst Pharmaceuticals	USD -4.51M	12.2M	2024-12
BioMarin Pharmaceutical	USD 198.39M	230.08M	2025-12
Esperion Therapeutics	USD -16.03M	11.51M	2024-09
Immunic	USD -22.81M	756K	2024-06
Insmed	USD -249.71M	11.64M	2025-12
Ionis Pharmaceuticals	USD -215M	54.82M	2025-12
Karyopharm Therapeutics	USD -26.28M	1.84M	2024-09
Kyowa Hakko Kirin	JPY 38.35B	12.49B	2025-12
MacroGenics	USD 20.16M	55.51M	2025-09
Moderna	USD -857M	597M	2025-12
Neurocrine Biosciences	USD 227.9M	11.4M	2025-12
PTC Therapeutics	USD -81.62M	85.11M	2025-12
Puma Biotechnology	USD -2.2M	11.41M	2024-06
Regeneron Pharmaceuticals	USD 898.6M	211.3M	2025-12
Sarepta Therapeutics	USD -410.08M	347.2M	2025-12
Ultragenyx Pharmaceutical	USD -114M	56.89M	2025-12
Vertex Pharmaceuticals	USD 1.26B	24.5M	2025-12
Xoma	USD -10.08M	4.4M	2024-06

Ultragenyx Pharmaceutical - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Mar 2026.